Cita APA

Beilman, C. L., Fedorak, R., & Halloran, B. P. (2018). A74 COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED TO INFLIXIMAB FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS. J Can Assoc Gastroenterol.

Citación estilo Chicago

Beilman, C L., R. Fedorak, y B P. Halloran. "A74 COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED TO INFLIXIMAB FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS." J Can Assoc Gastroenterol 2018.

Cita MLA

Beilman, C L., R. Fedorak, y B P. Halloran. "A74 COST-EFFECTIVENESS OF VEDOLIZUMAB COMPARED TO INFLIXIMAB FOR THE MANAGEMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS." J Can Assoc Gastroenterol 2018.